Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies.
about
Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Oncodriver inhibition and CD4+ ...... immune and targeted therapies.
@en
Oncodriver inhibition and CD4+ ...... immune and targeted therapies.
@nl
type
label
Oncodriver inhibition and CD4+ ...... immune and targeted therapies.
@en
Oncodriver inhibition and CD4+ ...... immune and targeted therapies.
@nl
prefLabel
Oncodriver inhibition and CD4+ ...... immune and targeted therapies.
@en
Oncodriver inhibition and CD4+ ...... immune and targeted therapies.
@nl
P2093
P2860
P356
P1433
P1476
Oncodriver inhibition and CD4+ ...... immune and targeted therapies.
@en
P2093
Amrita Basu
Brian J Czerniecki
Cinthia Rosemblit
Doris Wiener
Jashodeep Datta
Krithika Kodumudi
Lea Lowenfeld
P2860
P304
23058-23077
P356
10.18632/ONCOTARGET.25208
P407
P577
2018-05-01T00:00:00Z